This is a historical report — it no longer reflects this drug's current status. Current status: Active Shortage. View this drug's full profile page →
FINACEA
BAYER INC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of FINACEA in Canada?
Yes. FINACEA 15% has an active shortage reported to Health Canada (last updated October 27, 2026).
Why is FINACEA not available?
The reason the manufacturer reported: Demand increase for the drug.
When will FINACEA be available again?
The manufacturer's estimated resolution date is January 15, 2027. This is an estimate and can change; follow this page to get an email when the status changes.
What this means
Does this mean the shortage is completely over everywhere?
It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.
What should I do?
If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.
DIN
02270811
Strength
15%
Dosage Form
GEL
Route
TOPICAL
Active Ingredient
AZELAIC ACID
Tier
Unrated
Last Updated
2019-09-03
Reason for Shortage
Disruption of the manufacture of the drug.
Past Reports for This Drug
FINACEA has 2 shortage/discontinuation reports on file — this is one of them.
Other Products from BAYER INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
60MG · DIN 02155990
20MG · DIN 02237618
30MG · DIN 02155907
2.5MG · DIN 02412810
1MG · DIN 02412772
0.5MG · DIN 02412764
2MG · DIN 02412802
1.5MG · DIN 02412799
5MG · DIN 02243919
0.5MG · DIN 02247193
DIN 02309300
220MG · DIN 02436337